Cargando…
Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review
BACKGROUND: HIV viral load (VL) is currently not part of the criteria for Pneumocystis jirovecii pneumonia (PCP) prophylaxis discontinuation, but suppression of plasma viremia with antiretroviral therapy may allow for discontinuation of PCP prophylaxis even with CD4 count <200 cells/µL. METHODS:...
Autores principales: | Costiniuk, Cecilia T., Fergusson, Dean A., Doucette, Steve, Angel, Jonathan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241626/ https://www.ncbi.nlm.nih.gov/pubmed/22194853 http://dx.doi.org/10.1371/journal.pone.0028570 |
Ejemplares similares
-
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
por: Atkinson, Andrew, et al.
Publicado: (2021) -
Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana
por: Tenforde, Mark W., et al.
Publicado: (2021) -
Nonadherence to Primary Prophylaxis against Pneumocystis jirovecii Pneumonia
por: Heffelfinger, James D., et al.
Publicado: (2009) -
Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis
por: Dunbar, Albert, et al.
Publicado: (2020) -
Pneumocystis jirovecii Pneumonia in a HIV-Infected Patient with a CD4 Count Greater Than 400 Cells/μL and Atovaquone Prophylaxis
por: Sullivan, Abigayle, et al.
Publicado: (2020)